Results 31 to 40 of about 74,680 (298)

Polypharmacy in schizophrenia [PDF]

open access: yesBasic & Clinical Pharmacology & Toxicology, 2020
AbstractSchizophrenia is a severe mental disorder characterized by a heterogeneous symptom profile which comprises a clinical platform for widespread use of polypharmacy even though antipsychotic monotherapy is the recommended treatment regimen. This narrative review provides a summary of the current gap between evidence and practice for use of ...
openaire   +3 more sources

Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China

open access: yesBMC Geriatrics, 2023
Background Shared decision-making(SDM) is recognized as an important means of managing polypharmacy among older people with chronic diseases. However, no studies have quantitatively measured the effect of SDM on polypharmacy.
Qiao Zong   +5 more
doaj   +1 more source

Polypharmacy for schizophrenia [PDF]

open access: yesCurrent Opinion in Psychiatry, 2013
Combining psychotropic medications is common for people diagnosed with schizophrenia facing a variety of clinical circumstances. This review provides an update on evidence regarding the effectiveness of polypharmacy approaches.Epidemiology studies have demonstrated that polypharmacy is extremely common, but evidence regarding all polypharmacy ...
Jacob, Ballon, T Scott, Stroup
openaire   +2 more sources

Evaluation of Polypharmacy and Drug Interactions in the Treatment of Patients with Sepsis [PDF]

open access: yes, 2021
Objective:Comprehensive and supportive therapies of sepsis and septic shock (SSS) cause polypharmacy and increase the risk of drug interactions. This study aimed to evaluate the rate of polypharmacy, potential drug interactions, and clinical pharmacists’
Nursel Sürmelioğlu, Kutay Demirkan
core   +1 more source

Polypharmacy in African American Adults: A National Epidemiological Study

open access: yesPharmacy, 2019
Background: Despite the association between polypharmacy and undesired health outcomes being well established, very little is known about epidemiology of polypharmacy in the African American community.
Shervin Assari   +2 more
doaj   +1 more source

polypharmacy-dataset

open access: yes, 2019
Polypharmacy side-effects ...
Sameh Mohamed (4842612)
core   +1 more source

Level, pattern, and determinants of polypharmacy and inappropriate use of medications by village doctors in a rural area of Bangladesh [PDF]

open access: yes, 2014
Objective: Village doctors, informal health care providers practicing modern medicine, are dominant health care providers in rural Bangladesh. Given their role, it is important to examine their prescription pattern and inappropriate use of medication ...
Rasu, Rafia   +6 more
core   +2 more sources

Deprescribing and management of polypharmacy in the elderly

open access: yes, 2023
reservedBackground. La gestione della polifarmacoterapia e delle problematiche ad essa associate rappresentano un’importante sfida per il personale sanitario. La deprescrizione è una pratica di sospensione dei farmaci che viene messa in atto per ridurre
LOMBARDO, ALESSIA
core  

Polypharmacy and associated factors in South Korean elderly patients with dementia: An analysis using National Health Insurance claims data.

open access: yesPLoS ONE
BackgroundDementia is accompanied by several symptoms, including cognitive function decline, as well as behavioral and psychological symptoms. Elderly patients with dementia often experience polypharmacy, the concurrent use of multiple medications, due ...
Hea-Lim Kim, Hye-Jae Lee
doaj   +1 more source

Variation of polypharmacy in older primary care attenders occurs at prescriber level

open access: yesBMC Geriatrics, 2018
Background Polypharmacy is particularly important in older persons as they are more likely to experience adverse events compared to the rest of the population.
Su Miin Ong   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy